Laura Scandurra

Title: Laura Scandurra: Innovator in Pharmaceutical Compositions

Introduction

Laura Scandurra is a prominent inventor based in Catania, Italy. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions with antitumour activity. Her innovative work has led to the filing of multiple patents, showcasing her expertise and dedication to advancing medical science.

Latest Patents

Laura Scandurra holds 2 patents that focus on groundbreaking pharmaceutical compositions. One of her latest patents involves acylcarnitines, such as L-acetylcarnitine, which have demonstrated marked antitumour activity. This activity can be further enhanced by the simultaneous administration of somatostatin. Another patent addresses the use of acyl-carnitine for the treatment and prevention of viral infections, highlighting her commitment to addressing critical health challenges.

Career Highlights

Throughout her career, Laura has worked with esteemed institutions, including the Università Degli Studi Di Catania. Her research and innovations have positioned her as a key figure in the pharmaceutical industry, contributing to advancements that have the potential to improve patient outcomes.

Collaborations

Laura Scandurra has collaborated with notable professionals in her field, including Laure Aurelian and Franca Maria Stivala. These partnerships have enriched her research and expanded the impact of her work in the pharmaceutical sector.

Conclusion

Laura Scandurra's contributions to pharmaceutical innovations are noteworthy and reflect her dedication to improving health outcomes through her inventions. Her patents and collaborations underscore her role as a leading inventor in the field.